» Articles » PMID: 26654128

Hippocampal Dosimetry Correlates with the Change in Neurocognitive Function After Hippocampal Sparing During Whole Brain Radiotherapy: a Prospective Study

Overview
Journal Radiat Oncol
Publisher Biomed Central
Specialties Oncology
Radiology
Date 2015 Dec 15
PMID 26654128
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Whole brain radiotherapy (WBRT) has been the treatment of choice for patients with brain metastases. However, change/decline of neurocognitive functions (NCFs) resulting from impaired hippocampal neurogenesis might occur after WBRT. It is reported that conformal hippocampal sparing would provide the preservation of NCFs. Our study aims to investigate the hippocampal dosimetry and to demonstrate the correlation between hippocampal dosimetry and neurocognitive outcomes in patients receiving hippocampal sparing during WBRT (HS-WBRT).

Methods: Forty prospectively recruited cancer patients underwent HS-WBRT for therapeutic or prophylactic purposes. Before receiving HS-WBRT, all participants received a battery of baseline neurocognitive assessment, including memory, executive functions and psychomotor speed. The follow-up neurocognitive assessment at 4 months after HS-WBRT was also performed. For the delivery of HS-WBRT, Volumetric Modulated Arc Therapy (VMAT) with two full arcs and two non-coplanar partial arcs was employed. For each treatment planning, dose volume histograms were generated for left hippocampus, right hippocampus, and the composite hippocampal structure respectively. Biologically equivalent doses in 2-Gy fractions (EQD2) assuming an alpha/beta ratio of 2 Gy were computed. To perform analyses addressing the correlation between hippocampal dosimetry and the change in scores of NCFs, pre- and post-HS-WBRT neurocognitive assessments were available in 24 patients in this study.

Results: Scores of NCFs were quite stable before and after HS-WBRT in terms of hippocampus-dependent memory. Regarding verbal memory, the corresponding EQD2 values of 0, 10, 50, 80 % irradiating the composite hippocampal structure with <12.60 Gy, <8.81, <7.45 Gy and <5.83 Gy respectively were significantly associated with neurocognitive preservation indicated by the immediate recall of Word List Test of Wechsler Memory Scale-III. According to logistic regression analyses, it was noted that dosimetric parameters specific to left sided hippocampus exerted an influence on immediate recall of verbal memory (adjusted odds ratio, 4.08; p-value, 0.042, predicting patients' neurocognitive decline after receiving HS-WBRT).

Conclusions: Functional preservation by hippocampal sparing during WBRT is indeed achieved in our study. Providing that modern VMAT techniques can reduce the dose irradiating bilateral hippocampi below dosimetric threshold, patients should be recruited in prospective trials of hippocampal sparing during cranial irradiation to accomplish neurocognitive preservation while maintaining intracranial control.

Trial Registration: Current Controlled Trials NCT02504788.

Citing Articles

The effect of radiation dose to the brain on early self-reported cognitive function in brain and head-and-neck cancer patients.

Vaassen F, Hofstede D, Zegers C, Dijkstra J, Hoeben A, Anten M Clin Transl Radiat Oncol. 2025; 52:100929.

PMID: 40028425 PMC: 11869991. DOI: 10.1016/j.ctro.2025.100929.


Hippocampus-sparing volume-modulated arc therapy in patients with World Health Organization grade II glioma: a feasibility study.

Xie R, Huang H, Cai Q, Lu J, Chen T, Xie K Front Oncol. 2025; 14:1445558.

PMID: 39902134 PMC: 11788287. DOI: 10.3389/fonc.2024.1445558.


Current dilemma and future directions over prophylactic cranial irradiation in SCLC: a systematic review in MRI and immunotherapy era.

Tang L, Tian G, Li N Front Oncol. 2024; 14:1382220.

PMID: 39139283 PMC: 11319250. DOI: 10.3389/fonc.2024.1382220.


Assessment of different head tilt angles in volumetric modulated arc therapy for hippocampus-avoidance whole-brain radiotherapy.

Yuan C, Xu S, Li Y, Quan E, Chen D, Liang J Front Oncol. 2024; 14:1415471.

PMID: 38993636 PMC: 11236617. DOI: 10.3389/fonc.2024.1415471.


Efficacy and safety evaluation of combined therapies incorporating whole-brain radiotherapy in patients with brain metastases: a systematic review and meta-analysis.

Yan Q, Li R, Yang J, Bai X, Guo X, Yang X Clin Transl Oncol. 2024; 26(12):3020-3036.

PMID: 38789890 DOI: 10.1007/s12094-024-03525-1.


References
1.
Norden A, Wen P, Kesari S . Brain metastases. Curr Opin Neurol. 2005; 18(6):654-61. DOI: 10.1097/01.wco.0000191514.37498.2b. View

2.
Welzel G, Fleckenstein K, Schaefer J, Hermann B, Kraus-Tiefenbacher U, Mai S . Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys. 2008; 72(5):1311-8. DOI: 10.1016/j.ijrobp.2008.03.009. View

3.
Barani I, Cuttino L, Benedict S, Todor D, Bump E, Wu Y . Neural stem cell-preserving external-beam radiotherapy of central nervous system malignancies. Int J Radiat Oncol Biol Phys. 2007; 68(4):978-85. DOI: 10.1016/j.ijrobp.2007.01.064. View

4.
Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S . Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007; 68(5):1388-95. DOI: 10.1016/j.ijrobp.2007.03.048. View

5.
Gondi V, Tome W, Marsh J, Struck A, Ghia A, Turian J . Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Radiother Oncol. 2010; 95(3):327-31. PMC: 2981132. DOI: 10.1016/j.radonc.2010.02.030. View